ril 26, 2011 - MarketWatch.com AcelRx: Huge Poten
Post# of 144494
Posted On: 11/30/2013 5:27:27 PM
ril 26, 2011 - MarketWatch.com
AcelRx: Huge Potential With Limited Risk 1:54 p.m. Nov. 27, 2013 - Seeking Alpha
First Week Of ACRX January 2014 Options Trading 11:19 a.m. Nov. 19, 2013 - TheStreet.com
Top Insider Trades: AGCO VVUS INWK ACRX 9:52 a.m. Nov. 13, 2013 - TheStreet.com
Oversold Conditions For AcelRx Pharmaceuticals (ACRX) 11:59 a.m. Nov. 6, 2013 - TheStreet.com
AcelRx Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:34 p.m. Nov. 5, 2013 - Seeking Alpha
10-Q: ACELRX PHARMACEUTICALS INC 5:24 p.m. Nov. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
Top Insider Trades: ACW ZINC ACRX FCX 9:01 a.m. Nov. 5, 2013 - TheStreet.com
Our Best Small-Cap Biotech Picks For The Rest Of This Year 7:00 a.m. Oct. 15, 2013 - Seeking Alpha
AcelRx Gives Patent Update - Analyst Blog 4:05 p.m. Oct. 9, 2013 - Zacks.com
Little Known Cynapsus Underway To Solve Crucial Problem For Parkinson's Sufferers 4:42 a.m. Oct. 2, 2013 - Seeking Alpha
5 Biopharmas With Upcoming Catalysts That Should Rally 7:01 a.m. Sept. 27, 2013 - Seeking Alpha
AcelRx Pharmaceuticals To Submit NDA By End Of September, May Be Acquired Soon 6:55 a.m. Sept. 20, 2013 - Seeking Alpha
Upcoming Catalyst Could Spark Another Run For Insmed 10:22 a.m. Aug. 14, 2013 - Seeking Alpha
UPDATE: Jefferies Raises PT on AcelRx Pharmaceuticals on Numerous Potential Catalysts Ahead 6:42 a.m. Aug. 13, 2013 - benzinga.com
AcelRx Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript 8:19 p.m. Aug. 12, 2013 - Seeking Alpha
10-Q: ACELRX PHARMACEUTICALS INC 4:21 p.m. Aug. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Significant Near Term Catalyst Should Further Rally Keryx Pharmaceuticals 7:00 a.m. July 24, 2013 - Seeking Alpha
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock At $11.65 7:26 a.m. July 18, 2013 - benzinga.com
AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock 2:02 p.m. July 17, 2013 - benzinga.com
5 'Red Hot' Biotechs: Chen Lin 4:38 p.m. July 3, 2013 - Seeking Alpha
AcelRx Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:30 a.m. Nov. 26, 2013 - PR Newswire
Conference Call Schedules, Presentations, Collaborations and FDA Approvals - Research Report on Pharmacyclics, Pacira Pharmaceuticals, Raptor Pharmaceuticals, Impax Laboratories, and AcelRx 8:00 a.m. Nov. 6, 2013 - PR Newswire
AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:05 p.m. Nov. 5, 2013 - PR Newswire
AcelRx Pharmaceuticals Announces Data Presentations for Zalviso(TM) at US and International Medical Meetings 6:30 a.m. Oct. 15, 2013 - PR Newswire
AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso(TM) and its Proprietary Platform Technologies 6:30 a.m. Oct. 8, 2013 - PR Newswire
AcelRx Pharmaceuticals Submits New Drug Application to the FDA for Zalviso(TM) 6:30 a.m. Sept. 30, 2013 - PR Newswire
David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer 6:30 a.m. Sept. 4, 2013 - PR Newswire
AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013 10:52 a.m. Aug. 30, 2013 - PR Newswire
AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results 3:05 p.m. Aug. 12, 2013 - PR Newswire
AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference 6:30 a.m. Aug. 5, 2013 - PR Newswire
AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013 1:45 p.m. Aug. 2, 2013 - PR Newswire
AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares 12:00 p.m. July 23, 2013 - PR Newswire
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock 8:24 a.m. July 18, 2013 - PR Newswire
AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock 3:01 p.m. July 17, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACRX, AMTG, FTK and GLUU 7:51 a.m. July 15, 2013 - ACCESSWIRE
AcelRx Pharmaceuticals Joins Russell Global and Russell 3000 Indexes 6:30 a.m. July 2, 2013 - PR Newswire
AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 12:15 p.m. July 1, 2013 - PR Newswire
AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013 6:30 a.m. June 21, 2013 - PR Newswire
AcelRx Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare 6:30 a.m. May 29, 2013 - PR Newswire
Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6:30 a.m. May 21, 2013 - PR Newswire
$ACRX Company News
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 10:10 a.m. July 3, 2013 - Michael Ashbaugh
AcelRx Pharma offer 12.5M shares prices at $3.31 7:44 a.m. Dec. 7, 2012 - MarketWatch.com
AcelRx Pharma up 33% in premarket 8:05 a.m. Nov. 15, 2012 - Steve Gelsi
AcelRx rallies on drug study update 11:41 a.m. Jan. 31, 2012 - Val Brickates Kennedy
IPO scorecard: How recent offerings have performed 3:14 p.m. June 16, 2011 - MarketWatch.com
IPO scorecard: Pacira, Epocrates up in aftermarket 1:56 p.m. April 27, 2011 - MarketWatch.com
IPO Scorecard: Update on selected stock offerings 1:31 p.m. Ap
AcelRx: Huge Potential With Limited Risk 1:54 p.m. Nov. 27, 2013 - Seeking Alpha
First Week Of ACRX January 2014 Options Trading 11:19 a.m. Nov. 19, 2013 - TheStreet.com
Top Insider Trades: AGCO VVUS INWK ACRX 9:52 a.m. Nov. 13, 2013 - TheStreet.com
Oversold Conditions For AcelRx Pharmaceuticals (ACRX) 11:59 a.m. Nov. 6, 2013 - TheStreet.com
AcelRx Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:34 p.m. Nov. 5, 2013 - Seeking Alpha
10-Q: ACELRX PHARMACEUTICALS INC 5:24 p.m. Nov. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
Top Insider Trades: ACW ZINC ACRX FCX 9:01 a.m. Nov. 5, 2013 - TheStreet.com
Our Best Small-Cap Biotech Picks For The Rest Of This Year 7:00 a.m. Oct. 15, 2013 - Seeking Alpha
AcelRx Gives Patent Update - Analyst Blog 4:05 p.m. Oct. 9, 2013 - Zacks.com
Little Known Cynapsus Underway To Solve Crucial Problem For Parkinson's Sufferers 4:42 a.m. Oct. 2, 2013 - Seeking Alpha
5 Biopharmas With Upcoming Catalysts That Should Rally 7:01 a.m. Sept. 27, 2013 - Seeking Alpha
AcelRx Pharmaceuticals To Submit NDA By End Of September, May Be Acquired Soon 6:55 a.m. Sept. 20, 2013 - Seeking Alpha
Upcoming Catalyst Could Spark Another Run For Insmed 10:22 a.m. Aug. 14, 2013 - Seeking Alpha
UPDATE: Jefferies Raises PT on AcelRx Pharmaceuticals on Numerous Potential Catalysts Ahead 6:42 a.m. Aug. 13, 2013 - benzinga.com
AcelRx Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript 8:19 p.m. Aug. 12, 2013 - Seeking Alpha
10-Q: ACELRX PHARMACEUTICALS INC 4:21 p.m. Aug. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Significant Near Term Catalyst Should Further Rally Keryx Pharmaceuticals 7:00 a.m. July 24, 2013 - Seeking Alpha
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock At $11.65 7:26 a.m. July 18, 2013 - benzinga.com
AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock 2:02 p.m. July 17, 2013 - benzinga.com
5 'Red Hot' Biotechs: Chen Lin 4:38 p.m. July 3, 2013 - Seeking Alpha
AcelRx Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:30 a.m. Nov. 26, 2013 - PR Newswire
Conference Call Schedules, Presentations, Collaborations and FDA Approvals - Research Report on Pharmacyclics, Pacira Pharmaceuticals, Raptor Pharmaceuticals, Impax Laboratories, and AcelRx 8:00 a.m. Nov. 6, 2013 - PR Newswire
AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:05 p.m. Nov. 5, 2013 - PR Newswire
AcelRx Pharmaceuticals Announces Data Presentations for Zalviso(TM) at US and International Medical Meetings 6:30 a.m. Oct. 15, 2013 - PR Newswire
AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso(TM) and its Proprietary Platform Technologies 6:30 a.m. Oct. 8, 2013 - PR Newswire
AcelRx Pharmaceuticals Submits New Drug Application to the FDA for Zalviso(TM) 6:30 a.m. Sept. 30, 2013 - PR Newswire
David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer 6:30 a.m. Sept. 4, 2013 - PR Newswire
AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013 10:52 a.m. Aug. 30, 2013 - PR Newswire
AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results 3:05 p.m. Aug. 12, 2013 - PR Newswire
AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference 6:30 a.m. Aug. 5, 2013 - PR Newswire
AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013 1:45 p.m. Aug. 2, 2013 - PR Newswire
AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares 12:00 p.m. July 23, 2013 - PR Newswire
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock 8:24 a.m. July 18, 2013 - PR Newswire
AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock 3:01 p.m. July 17, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACRX, AMTG, FTK and GLUU 7:51 a.m. July 15, 2013 - ACCESSWIRE
AcelRx Pharmaceuticals Joins Russell Global and Russell 3000 Indexes 6:30 a.m. July 2, 2013 - PR Newswire
AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 12:15 p.m. July 1, 2013 - PR Newswire
AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013 6:30 a.m. June 21, 2013 - PR Newswire
AcelRx Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare 6:30 a.m. May 29, 2013 - PR Newswire
Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6:30 a.m. May 21, 2013 - PR Newswire
$ACRX Company News
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 10:10 a.m. July 3, 2013 - Michael Ashbaugh
AcelRx Pharma offer 12.5M shares prices at $3.31 7:44 a.m. Dec. 7, 2012 - MarketWatch.com
AcelRx Pharma up 33% in premarket 8:05 a.m. Nov. 15, 2012 - Steve Gelsi
AcelRx rallies on drug study update 11:41 a.m. Jan. 31, 2012 - Val Brickates Kennedy
IPO scorecard: How recent offerings have performed 3:14 p.m. June 16, 2011 - MarketWatch.com
IPO scorecard: Pacira, Epocrates up in aftermarket 1:56 p.m. April 27, 2011 - MarketWatch.com
IPO Scorecard: Update on selected stock offerings 1:31 p.m. Ap
(0)
(0)Scroll down for more posts ▼